scholarly journals Long-Term Incidence of Atrial Fibrillation and Stroke Among Cross-Country Skiers: Cohort Study of Endurance-Trained Male and Female Athletes

Author(s):  
Niclas Svedberg ◽  
Johan Sundström ◽  
Stefan James ◽  
Ulf Hållmarker ◽  
Kristina Hambraeus ◽  
...  
Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S129
Author(s):  
Linh Thi Hai Ngo ◽  
Richard Woodman ◽  
Russell A. Denman ◽  
Tomos E. Walters ◽  
Ian Yang ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e028468 ◽  
Author(s):  
A Gundlund ◽  
Thomas Kümler ◽  
Anders Nissen Bonde ◽  
Jawad Haider Butt ◽  
Gunnar Hilmar Gislason ◽  
...  

ObjectivesWe compared long-term outcomes in patients with atrial fibrillation (AF) with and without a secondary precipitant.Design and settingRetrospective cohort study based on Danish nationwide registries.ParticipantsPatients with AF with and without secondary precipitants (1996–2015) were matched 1:1 according to age, sex, calendar year, CHA2DS2-VASc score and oral anticoagulation therapy (OAC), resulting in a cohort of 39 723 patients with AF with a secondary precipitant and the same number of patients with AF without a secondary precipitant. Secondary precipitants included alcohol intoxication, thyrotoxicosis, myocardial infarction, surgery and infection in conjunction with AF.Primary and secondary outcomesThe primary outcome in this study was thromboembolic events. Secondary outcomes included AF rehospitalisation and death. Long-term risks of outcomes were examined by multivariable Cox regression analysis.ResultsThe most common precipitants were infection (55.0%), surgery (13.2%) and myocardial infarction (12.0%). The 5-year absolute risk of thromboembolic events (taking death into account as a competing risk) in patients with AF grouped according to secondary precipitants were 8.3% (alcohol intoxication), 8.5% (thyrotoxicosis), 12.1% (myocardial infarction), 11.6% (surgery), 12.2% (infection), 10.1% (>1 precipitant) and 12.3% (no secondary precipitant). In the multivariable analyses, AF with a secondary precipitant was associated with the same or an even higher thromboembolic risk than AF without a secondary precipitant. One exception was patients with AF and thyrotoxicosis: those not initiated on OAC therapy carried a lower thromboembolic risk the first year of follow-up than matched patients with AF without a secondary precipitant and no OAC therapy.ConclusionsIn general, AF with a secondary precipitant was associated with the same thromboembolic risk as AF without a secondary precipitant. Consequently, this study highlights the need for more research regarding the long-term management of patients with AF associated with a secondary precipitant.


2013 ◽  
Vol 168 (4) ◽  
pp. 4367-4369 ◽  
Author(s):  
Chen-Ying Hung ◽  
Yu-Cheng Hsieh ◽  
Kuo-Yang Wang ◽  
Jin-Long Huang ◽  
El-Wui Loh ◽  
...  

2020 ◽  
Vol 27 (19) ◽  
pp. 2354-2357
Author(s):  
Setor K Kunutsor ◽  
Jari A Laukkanen ◽  
Sudhir Kurl ◽  
Timo H Mäkikallio ◽  
Hassan Khan

2019 ◽  
Vol 94 (2) ◽  
pp. 225-235 ◽  
Author(s):  
Yeong-Min Lim ◽  
Pil-Sung Yang ◽  
Eunsun Jang ◽  
Hee Tae Yu ◽  
Tae-Hoon Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document